Sunil Healthcare Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sunil Healthcare Ltd. on BSE

Search Inside the pdf :

Sunil Healthcare Ltd.

18 Jul 2025

82.55

1.79%

Board Meeting

Sunil Healthcare Ltd - 537253 - Board Meeting Intimation for Intimation Of The Board Meeting Scheduled …

BSE India

Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 ,inter alia, to consider and approve 264th Meeting of the Board of Directors of the Company, is scheduled to be held on Wednesday, July 30, 2025, inter alia, to consider, approve and take on record the Un-Audited Financial Results (both standalone and consolidated) for the 1st quarter of the Financial year 2025-26 ended on June 30, 2025.

pdf

Sunil Healthcare Ltd.

08 Jul 2025

82.55

1.79%

Company Update

Sunil Healthcare Ltd - 537253 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2025

pdf

Sunil Healthcare Ltd.

27 Jun 2025

82.55

1.79%

SAST

Sunil Healthcare Ltd - 537253 - Closure of Trading Window

BSE India

Intimation of Closure of Trading Window for the Un-audited financial results for the 1st quarter ended 30.06.2025 of FY 2025-26.

pdf

Sunil Healthcare Ltd.

31 May 2025

82.55

1.79%

Company Update

Sunil Healthcare Ltd - 537253 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Copy of newspaper clipping regarding publication of audited financial results for the quarter/year ended 31.03.2025

pdf

Sunil Healthcare Ltd.

30 May 2025

82.55

1.79%

Company Update

Sunil Healthcare Ltd - 537253 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report under Regulation 24A of SEBI (LODR) Regulations, 2015 for the financial year 2024-25 ended on 31.03.2025 issued by ATCS & Associates, Company Secretaries.

pdf

Sunil Healthcare Ltd.

29 May 2025

82.55

1.79%

Company Update

Sunil Healthcare Ltd - 537253 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015

BSE India

Board at their meeting held on 29.05.2025 interalia approved M/s. ATCS & Associates, Company Secretaries as Secretarial Auditor of the Company for a term of 5 consecutive years from FY 2025-26 to FY2029-30 subject to approval of members of the Company at the ensuing Annual General Meeting of the Company.

pdf

Sunil Healthcare Ltd.

29 May 2025

82.55

1.79%

Board Meeting

Sunil Healthcare Ltd - 537253 - Board Meeting Outcome for Outcome Of The 263Rd Board Meeting …

BSE India

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are pleased to inform, inter-alia the outcome of the Meeting of the Board of Directors of the Company held on Thursday, May 29, 2025, at 04:20 p.m. and concluded at 6.55 p.m. 1. Approved Audited Financial Results (standalone and consolidated) for the quarter/year ended March 31, 2025. 2. Noted Auditors Report on Annual Audited Financial Statement (both standalone & Consolidated) for the financial year ended March 31, 2025 alongwith declaration from the CFO that Auditors report contain unmodified opinion on financial Results. 3. approved the appointment of M/s. ATCS & Associates, Company Secretaries (Unique Identification No: P2017RJ063900 and Peer Review Certificate No. 3381/2023) as Secretarial Auditor of the Company

pdf

Sunil Healthcare Ltd.

29 May 2025

82.55

1.79%

Result

Sunil Healthcare Ltd - 537253 - Financial Results For The Quarter/Year Ended 31.03.2025

BSE India

Board at their meeting held on 29.05.2025 interalia approved audited standalone and consolidated financial results for the quarter/year ended 31.03.2025.

pdf

Sunil Healthcare Ltd.

19 May 2025

82.55

1.79%

Board Meeting

Sunil Healthcare Ltd - 537253 - Board Meeting Intimation for Intimation Of The Board Meeting Scheduled …

BSE India

Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, the Meeting of the Board of Directors of the Company, is scheduled to be held on Thursday, May 29, 2025, at Registered office of the Company inter alia, to consider, approve and take on record the Audited Financial Results (both standalone and consolidated) for the 4th quarter of FY 2024-25 and for the Financial year 2024-25 ended on March 31, 2025.

pdf

Sunil Healthcare Ltd.

23 Apr 2025, 11:07AM

82.55

1.79%

Corp. Note

Sunil Healthcare Ltd - 537253 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySunil Healthcare Ltd 2CIN NO.L24302DL1973PLC189662 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 24.16 4Highest Credit Rating during the previous FY BBB- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: SATYENDU PATTNAIK Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: cs@sunilhealthcare.com Name of the Chief Financial Officer: PAWAN RATHI Designation: CHIEF FINANCIAL OFFICER EmailId: cfo@sunilhealthcare.com Date: 23/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Is Sunil Healthcare Ltd. worth buying?

65 Votes:

Buy 64.62%

Sell 30.77%

Hold 4.62%